Oregon Public Employees Retirement Fund trimmed its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 0.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 31,128 shares of the financial services provider’s stock after selling 83 shares during the period. Oregon Public Employees Retirement Fund’s holdings in CME Group were worth $8,579,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of the stock. Great Lakes Advisors LLC raised its stake in shares of CME Group by 2.3% during the first quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock valued at $441,000 after acquiring an additional 37 shares in the last quarter. Beaumont Financial Advisors LLC grew its stake in CME Group by 2.0% in the second quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider’s stock worth $538,000 after purchasing an additional 38 shares in the last quarter. Trifecta Capital Advisors LLC increased its holdings in CME Group by 59.2% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 42 shares during the period. OneAscent Financial Services LLC raised its position in CME Group by 4.0% during the 1st quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider’s stock valued at $293,000 after purchasing an additional 43 shares in the last quarter. Finally, Highline Wealth Partners LLC lifted its holdings in shares of CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after buying an additional 43 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.
CME Group Stock Performance
Shares of CME stock opened at $271.45 on Monday. CME Group Inc. has a 12-month low of $213.94 and a 12-month high of $290.79. The business’s fifty day simple moving average is $268.89 and its 200-day simple moving average is $271.29. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a market cap of $97.83 billion, a PE ratio of 26.28, a PEG ratio of 5.72 and a beta of 0.41.
CME Group Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were paid a $1.25 dividend. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. CME Group’s dividend payout ratio (DPR) is 48.40%.
Insider Transactions at CME Group
In related news, insider Sunil Cutinho sold 11,896 shares of the company’s stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the sale, the insider owned 17,440 shares in the company, valued at $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the transaction, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. This trade represents a 3.83% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 13,043 shares of company stock worth $3,527,956. 0.30% of the stock is owned by insiders.
Analyst Ratings Changes
Several brokerages have recently commented on CME. Piper Sandler raised their price target on CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research note on Tuesday, July 15th. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $246.00 to $252.00 and gave the company an “underweight” rating in a research note on Thursday, September 25th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of CME Group from $276.00 to $266.00 and set a “hold” rating for the company in a research note on Thursday. Barclays dropped their target price on CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Finally, UBS Group reduced their price target on CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a research report on Monday, September 8th. Seven research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $281.00.
Check Out Our Latest Analysis on CME
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 Copper Stocks Ready to Shine in the Next Metal Supercycle
- What is the Dow Jones Industrial Average (DJIA)?
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- Quiet Period Expirations Explained
- Could Target’s Week of Discounts Come Full Circle for Investors?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.